Average Co-Inventor Count = 5.27
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Smithkline Beecham Corporation (27 from 2,198 patents)
2. Astex Therapeutics Limited (20 from 123 patents)
3. Glaxo Group Limited (12 from 1,168 patents)
4. Cancer Research Technology Limited (5 from 262 patents)
5. Otsuka Pharmaceutical Company, Limited (2 from 845 patents)
6. Taiho Pharmaceutical Company Limited (2 from 318 patents)
7. Beecham Group Plc (1 from 855 patents)
62 patents:
1. 12202828 - Bicyclic heterocycle compounds and their uses in therapy
2. 12071429 - Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
3. 12037345 - Heterobicyclic compounds for inhibiting the activity of SHP2
4. 11866428 - Bicyclic heterocycle compounds and their uses in therapy
5. 11643410 - Bicyclic heterocycle compounds and their uses in therapy
6. 11466016 - Pharmaceutical compounds
7. 11261171 - Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
8. 11225476 - Bicyclic heterocycle compounds and their uses in therapy
9. 10981898 - Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity
10. 10618895 - Bicyclic heterocycle compounds and their uses in therapy
11. 10544132 - Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity
12. 10526311 - Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
13. 9980973 - Bicyclic heterocycle compounds and their uses in therapy
14. 9850228 - Pyrazolyl quinoxaline kinase inhibitors
15. 9783538 - Bicyclic heterocycle compounds and their uses in therapy